Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients-Reference-Cited by-同舟云学术

Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients

Published:2015-10-01 Issue:12 Volume:64 Page:1565-1573
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Araki Hiromitsu,Pang Xiaoliang,Komatsu Nobukazu,Soejima Mikiko,Miyata Nawoe,Takaki Mari,Muta Shigeru,Sasada Tetsuro,Noguchi Masanori,Koda Yoshiro,Itoh Kyogo,Kuhara Satoru,Tashiro Kosuke

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-015-1756-7.pdf

Reference34 articles.

1. Noguchi M, Sasada T, Itoh K (2013) Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine. Cancer Immunol Immunother 62:919–929 (review)

2. Yamada A, Sasada T, Noguchi M, Itoh K (2013) Next-generation peptide vaccines for advanced cancer. Cancer Sci 104:15–21 (review)

3. Yajima N, Yamanaka R, Mine T, Tsuchiya N, Homma J, Sano M, Kuramoto T, Obata Y, Komatsu N, Arima Y, Yamada A, Shigemori M et al (2005) Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma. Clin Cancer Res 11:5900–5911

4. Terasaki M, Shibui S, Narita Y, Fujimaki T, Aoki T, Kajiwara K, Sawamura Y, Kurisu K, Mineta T, Yamada A, Itoh K (2011) Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen-A24 with recurrent or progressive glioblastoma multiforme. J Clin Oncol 29:337–344

5. Noguchi M, Moriya F, Suekane S, Matsuoka K, Arai G, Matsueda S, Sasada T, Yamada A, Itoh K (2012) Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy. Prostate 72:834–845

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-cancer scRNA-seq analysis reveals immunological and diagnostic significance of the peripheral blood mononuclear cells;Human Molecular Genetics;2023-11-07

2. Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data;2022-07-31

3. FOXA1 overexpression suppresses interferon signaling and immune response in cancer;Journal of Clinical Investigation;2021-07-15

4. Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities;Vaccines;2021-06-09

5. Discrimination of a single nucleotide polymorphism in the haptoglobin promoter region, rs5472, using a competitive fluorophore-labeled probe hybridization assay following loop-mediated isothermal amplification;Bioscience, Biotechnology, and Biochemistry;2021-01-20